Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 1, 2004, Pages 105-113

  Hansen, Suzanne L ^a   Sperling, Bonnie B ^a   Sánchez, Connie ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

Epilepsy; GABA aminobutyric acid; Kindling; Pentylenetetrazole; Pentylenetetrazole induced seizure

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALFAXALONE; BENZODIAZEPINE; BICUCULLINE; DIAZEPAM; FLUMAZENIL; GABOXADOL; LIGAND; PENTETRAZOLE; PRASTERONE SULFATE;

AGONIST; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CHRONIC DRUG ADMINISTRATION; CLONIC SEIZURE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BINDING SITE; DRUG EFFECT; DRUG INHIBITION; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; EXPERIMENTAL HOST; GABAERGIC TRANSMISSION; KINDLING; MALE; MOUSE; NONHUMAN; SINGLE DRUG DOSE; SPECIES COMPARISON;

EID: 0346365451     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2003.09.026     Document Type: Article

References (41)

1. Albertson T.E., Walby W.F. Effects of the benzodiazepine antagonists RO 15-1788, CGS-8216 and PK-11195 on amygdaloid kindled seizures and the anticonvulsant efficacy of diazepam. Neuropharmacology. 25:1986;1205-1211.
2. Bazyan A.S., Zhulin V.V., Karpova M.N., Klishina N.Y., Glebov R.N. Long-term reduction of benzodiazepine receptor density in the rat cerebellum by acute seizures and kindling and its recovery 6 months later by a pentylenetetrazole challenge. Brain Res. 888:2001;212-220.
3. Beekman M., Ungard J.T., Gasior M., Carter R.B., Dijkstra D., Goldberg S.R., Witkin J.M. Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone. J. Pharmacol. Exp. Ther. 284:1998;868-877.
4. Christensen A.V., Larsen J.J. Antinociceptive and anticonvulsive effect of THIP, a pure GABA agonist. Pol. J. Pharmacol. Pharm. 34:1982;127-134.
5. Corda M.G., Orlandi M., Giorgi O. Decrease in GABAergic function induced by pentylenetetrazol kindling in rats: antagonism by MK-801. J. Pharmacol. Exp. Ther. 262:1992;792-800.
6. Czlonkowska A.I., Krzascik P., Sienkiewicz-Jarosz H., Siemiatkowski M., Szyndler J., Bidzinski A., Plaznik A. The effects of neurosteroids on picrotoxin-, bicuculline- and NMDA-induced seizures, and a hypnotic effect of ethanol. Pharmacol. Biochem. Behav. 67:2000;345-353.
7. Ebert U., Cramer S., Loscher W. Phenytoin's effect on the spread of seizure activity in the amygdala kindling model. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;341-347.
8. Ebert B., Wafford K.A., Whiting P.J., Krogsgaard-Larsen P., Kemp J.A. Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations. Mol. Pharmacol. 46:1994;957-963.
9. Ekonomou A., Smith A.L., Angelatou F. Changes in AMPA receptor binding and subunit messenger RNA expression in hippocampus and cortex in the pentylenetetrazole-induced "kindling" model of epilepsy. Brain Res. Mol. Brain Res. 95:2001;27-35.
10. Erakovic V., Zupan G., Varljen J., Laginja J., Simonic A. Altered activities of rat brain metabolic enzymes caused by pentylenetetrazol kindling and pentylenetetrazol-induced seizures. Epilepsy Res. 43:2001;165-173.
11. Facklam M., Schoch P., Bonetti E.P., Jenck F., Martin J.R., Moreau J.L., Haefely W.E. Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies. J. Pharmacol. Exp. Ther. 261:1992;1113-1121.
12. Fisher R.S. Animal models of the epilepsies. Brain Res. Brain Res. Rev. 14:1989;245-278.
13. Follesa P., Tarantino A., Floris S., Mallei A., Porta S., Tuligi G., Cagetti E., Caddeo M., Mura A., Serra M., Biggio G. Changes in the gene expression of GABAA receptor subunit mRNAs in the septum of rats subjected to pentylenetetrazol-induced kindling. Brain Res. Mol. Brain Res. 70:1999;1-8.
14. Fowler J., Cohen L. Practical Statistics for Field Biology. 1996;John Wiley and Sons Ltd. Chichester, UK.
15. Gasior M., Ungard J.T., Beekman M., Carter R.B., Witkin J.M. Acute and chronic effects of the synthetic neuroactive steroid, ganaxolone, against the convulsive and lethal effects of pentylenetetrazol in seizure-kindled mice: comparison with diazepam and valproate. Neuropharmacology. 39:2000;1184-1196.
16. B receptor antagonism on the development of pentylenetetrazol-induced kindling in mice. Brain Res. 809:1998;182-188.
17. Goddard G.V., McIntyre D.C., Leech C.K. A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 25:1969;295-330.
18. Gower A.J., Noyer M., Verloes R., Gobert J., Wulfert E. ucb L059, a novel anti-convulsant drug: pharmacological profile in animals. Eur. J. Pharmacol. 222:1992;193-203.
19. Holland K.D., McKeon A.C., Canney D.J., Covey D.F., Ferrendelli J.A. Relative anticonvulsant effects of GABA mimetic and GABA modulatory agents. Epilepsia. 33:1992;981-986.
20. Huang R.Q., Bell-Horner C.L., Dibas M.I., Covey D.F., Drewe J.A., Dillon G.H. Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action. J. Pharmacol. Exp. Ther. 298:2001;986-995.
21. Klitgaard H., Matagne A., Gobert J., Wulfert E. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur. J. Pharmacol. 353:1998;191-206.
22. Kupferberg H. Animal models used in the screening of antiepileptic drugs. Epilepsia. 42(Suppl. 4):2001;7-12.
23. Lason W., Turchan J., Przewlocka B., Labuz D., Machelska H., Przewlocki R. Effects of pentylenetetrazol kindling on glutamate receptor genes expression in the rat hippocampus. Brain Res. 785:1998;355-358.
24. Loscher W. Comparative assay of anticonvulsant and toxic potencies of sixteen GABA mimetic drugs. Neuropharmacology. 21:1982;803-810.
25. Loscher W., Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2:1988;145-181.
26. Mason C.R., Cooper R.M. A permanent change in convulsive threshold in normal and brain-damaged rats with repeated small doses of pentylenetetrazole. Epilepsia. 13:1972;663-674.
27. A receptor function by chronic exposure to GABA-neutral and GABA-negative benzodiazepine ligands in cultured cortical neurons. Biochem. Pharmacol. 40:1990;1337-1344.
28. 2+/calmodulin- dependent protein phosphorylation. Neurosci. Res. 11:1991;146-153.
29. Onozuka M., Watanabe K. Intracellularly applied anti-P70 antibody blocks the induction of abnormal membrane properties by pentylenetetrazole in identified Euhadra neurons. Brain Res. 716:1996;187-191.
30. Pellmar T.C., Wilson W.A. Synaptic mechanism of pentylenetetrazole: selectivity for chloride conductance. Science. 197:1977;912-914.
31. Peterson S.L. Anticonvulsant profile of an anesthetic steroid. Neuropharmacology. 28:1989;877-879.
32. Ramanjaneyulu R., Ticku M.K. Interactions of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine-GABA receptor-ionophore complex. Eur. J. Pharmacol. 98:1984;337-345.
33. Robertson H.A., Riives M.L. A benzodiazepine antagonist is an anticonvulsant in an animal model for limbic epilepsy. Brain Res. 270:1983;380-382.
34. Rocha L., Ackermann R.F., Engel J.J. Chronic and single administration of pentylenetetrazol modifies benzodiazepine receptor-binding: an autoradiographic study. Epilepsy Res. 24:1996;65-72.
35. Schroeder H., Becker A., Hoellt V. Sensitivity and density of glutamate receptor subtypes in the hippocampal formation are altered in pentylenetetrazole-kindled rats. Exp. Brain Res. 120:1998;527-530.
36. Serra M., Dazzi L., Pisu M.G., Cagetti E., Biggio G. Reversal of a selective decrease in hippocampal acetylcholine release, but not of the persistence of kindling, after discontinuation of long-term pentylenetetrazol administration in rats. Brain Res. 751:1997;175-179.
37. Sousa A., Ticku M.K. Interactions of the neurosteroid dehydroepiandrosterone sulfate with the GABA(A) receptor complex reveals that it may act via the picrotoxin site. J. Pharmacol. Exp. Ther. 282:1997;827-833.
38. Szot P., White S.S., Veith R.C. Effect of pentylenetetrazol on the expression of tyrosine hydroxylase mRNA and norepinephrine and dopamine transporter mRNA. Brain Res. Mol. Brain Res. 44:1997;46-54.
39. Walsh L.A., Li M., Zhao T.J., Chiu T.H., Rosenberg H.C. Acute pentylenetetrazol injection reduces rat GABAA receptor mRNA levels and GABA stimulation of benzodiazepine binding with no effect on benzodiazepine binding site density. J. Pharmacol. Exp. Ther. 289:1999;1626-1633.
40. Yajima Y., Narita M., Takahashi-Nakano Y., Misawa M., Nagase H., Mizoguchi H., Tseng L.F., Suzuki T. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse. Brain Res. 862:2000;120-126.
41. Zheng T.M., Caruncho H.J., Zhu W.J., Vicini S., Ikonomovic S. Chronic flumazenil alters GABAA subunit mRNA expression, translation product assembly and channel function in neuronal cultures. J. Pharmacol. Exp. Ther. 277:1996;525-533.